Key result
Elevated Lp(a)-to-HDL-C ratio linked to higher risk of repeat revascularization and ISR post-PCI.
Why the study?
The study was conducted to examine the association between a novel lipoprotein(a)-to-HDL-C ratio and repeat revascularization and in-stent restenosis in chronic coronary syndrome patients after PCI.
Does an elevated Lipoprotein(a)-to-HDL-C ratio predict the risk of repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome after PCI?
Cohort (n=2,238)
Does an elevated Lipoprotein(a)-to-HDL-C ratio predict the risk of repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome after PCI?
An elevated Lipoprotein(a)-to-HDL-C ratio is an independent predictor of repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome after PCI, offering a complementary marker for long-term risk stratification.
Answers are grounded in this paper and cite their sources.
LHR may stratify repeat revascularization risk after PCI in CCS; hypothesis-generating and needs prospective validation before clinical adoption.
BACKGROUND: We proposed a novel lipoprotein(a)-to-HDL-C ratio (LHR) and examined its association with repeat revascularization and in-stent restenosis (ISR) in patients with chronic coronary syndrome (CCS) after percutaneous coronary intervention (PCI). METHODS: A total of 2,238 patients with CCS undergoing DES-PCI who had available follow-up coronary imaging were included and categorized into tertiles according to lnLHR values. The primary outcome was a composite of repeat revascularization and ISR. Kaplan-Meier analysis, multivariable Cox regression, restricted cubic spline analysis, and prediction model evaluation were performed. RCS analysis demonstrated a linear association between lnLHR and outcomes. The LHR-based model showed modest discrimination, with AUCs of 0.629 at 3 years and 0.648 at 5 years. CONCLUSIONS: An elevated LHR was independently associated with an increased risk of repeat revascularization and ISR after PCI in CCS patients. These findings suggest that LHR may serve as a complementary lipid-related marker for long-term risk stratification in this population.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) conducted a cohort in Chronic coronary syndrome (n=2,238). Elevated Lipoprotein(a)-to-HDL-C ratio (LHR) vs. Lower LHR tertiles was evaluated on Composite of repeat revascularization and in-stent restenosis (ISR) (p=0.026). An elevated lipoprotein(a)-to-HDL-C ratio was independently associated with an increased risk of repeat revascularization and in-stent restenosis after PCI in patients with chronic coronary syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: